SEC Form 4 · accession 0001235802-18-000123
Xtant Medical Holdings, Inc. · XTNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carl O'Connell
Officer — Chief Executive Officer
Period of report
Aug 15, 2018
Accepted (ET)
Aug 16, 2018 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001453593
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.000001 par value | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $6.20 | Aug 15, 2018 | A | 200,000 | A | — | Aug 15, 2028 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1This option vests with respect to 50,000 shares on each of August 15, 2019, August 15, 2020, August 15, 2021 and August 15, 2022, subject to such Reporting Person's continued employment with Xtant Medical Holdings, Inc.